Increasing incidence of resistance of gram-negative bacteria against even newer antibiotic
including carbapenem has generated interest in the old antibiotic colistin, which are being …

This review critically appraises the published microbiologic and clinical data on the
treatment of patients with carbapenem‐resistant Acinetobacter baumannii infections …

Aminoglycosides are a family of rapidly bactericidal antibiotics that often remain active
against resistant Gram-negative bacterial infections. Over the past decade, their use in …

Background An optimal therapy for the treatment of pneumonia caused by drug-resistant
Acinetobacter baumannii remains unclear. This study aims to compare various antimicrobial …

Introduction: The emergence of multidrug-resistant gram-negative bacteria has led to the
increasing use of polymyxins. Nephrotoxicity and, to a lesser degree, neurotoxicity occur …

ABSTRACT Introduction: Non-fermenting Gram-negative bacilli are at the center of the
antimicrobial resistance epidemic. Acinetobacter baumannii and Pseudomonas aeruginosa …

The prevalence of carbapenem-resistant gram-negative bacterial pathogens (CRGNs) has
increased dramatically during the last 10 years, but the optimal treatment for CRGN …

Bacteria within the genus Acinetobacter (principally A. baumannii-calcoaceticus complex
[ABC]) are gram-negative coccobacilli that may cause nosocomial infections in critically ill or …

Polymyxins are commonly used as the last resort for the treatment of MDR Acinetobacter
baumannii and Klebsiella pneumoniae nosocomial infections; however, apart from the …

Evidence-based, standard antibiotic therapy for ventilator-associated pneumonia (VAP)
caused by carbapenem-resistant Acinetobacter baumannii (CRAB) is a relevant unmet …